Clinical
Clinical Pathways in Oncology
Danielle Barron reports on the increasing popularity of evidence-based clinical pathways & the implications for manufacturers.
More Clinical Articles
Clinical
Payer-Reform for Physicians — Moving from Volume-Based to Value-Based Reimbursement
Dr Edward J. Benz, CEO of Dana Farber Cancer Institute discusses physician payment reform and its practical implications.
Clinical
The Future of Clinical Trials
Patient-centric trials offer huge opportunity but what are the barriers to implementation?
Clinical
Successful Pharmacovigilance: Harnessing Relationships between Stakeholders
What makes pharmacovigilance effective and efficient is the trust between the different parties and stakeholders.
Clinical
4 Ways to Guarantee your Trials Become More Patient-Centric
Could trials be at risk of being invalidated by rebellion from patients?
Clinical
Risk Sharing Agreements on the American Horizon
US stakeholders are beginning to consider risk sharing agreements, but to what effect?
Clinical
Alzheimer’s: Can we save the world from a public health disaster?
Alzheimer’s disease is a ticking time bomb for public health around the world. If we don’t act now, it will single-handedly devastate global healthcare systems.
Clinical
Partnership: The Game Changer in Alzheimer’s Research
A unique public-private partnership aims to change the face of Alzheimer’s dementia research by avoiding the duplication of research efforts. Danielle Barron speaks to those involved to find out why this new approach may finally lead to effective treatments for the condition.
Clinical
Patient Centered Clinical Trials
As pharmaceutical companies compete to bring new drugs to market, there is an increasing emphasis on the need for patient centricity – to retain patient volunteers and produce quality data. We spoke to Duncan Cantor, Director of Communications, Boehringer Ingelheim, about the importance of patient centricity in clinical trials.
Clinical
Time to flourish
Failure is going to be part of the process with biosimilars, but for companies with an entrepreneurial spirit and a clear mindset, the rewards are also there...